Found: 3
Select item for more details and to access through your institution.
PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e520, doi. 10.1634/theoncologist.2019-0557
- By:
- Publication type:
- Article
Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6225, doi. 10.3390/cancers13246225
- By:
- Publication type:
- Article
Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 920, doi. 10.3390/cancers11070920
- By:
- Publication type:
- Article